GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Revenue

Whanin Pharm Co (XKRX:016580) Revenue : ₩236,463 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Revenue?

Whanin Pharm Co's revenue for the three months ended in Mar. 2024 was ₩61,610 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩236,463 Mil. Whanin Pharm Co's Revenue per Share for the three months ended in Mar. 2024 was ₩4,034.45. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩15,485.72.

Good Sign:

Whanin Pharm Co Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Whanin Pharm Co was 14.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Whanin Pharm Co's highest 3-Year average Revenue per Share Growth Rate was 11.90% per year. The lowest was -1.90% per year. And the median was 5.55% per year.


Whanin Pharm Co Revenue Historical Data

The historical data trend for Whanin Pharm Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Revenue Chart

Whanin Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 159,176.97 171,705.41 177,775.70 198,934.73 230,393.58

Whanin Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55,540.28 57,626.10 58,841.22 58,385.99 61,610.03

Competitive Comparison of Whanin Pharm Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Whanin Pharm Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Whanin Pharm Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Whanin Pharm Co's Revenue distribution charts can be found below:

* The bar in red indicates where Whanin Pharm Co's Revenue falls into.



Whanin Pharm Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩236,463 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Whanin Pharm Co  (XKRX:016580) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Whanin Pharm Co Revenue Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Whanin Pharm Co (XKRX:016580) Business Description

Traded in Other Exchanges
N/A
Address
84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines